All News

The iron-based brain MRI contrast agent Ferabright (ferumoxytol injection) is indicated for adult patients with known or suspected malignant neoplasms.

Concordant mammography detection of breast cancer by radiologists and AI had over a threefold higher likelihood of future incidental breast cancer in comparison to positive radiologist assessment and negative AI evaluation, according to new research involving over 82,000 women.

The AI-enabled LungQ® 4 software reportedly offers enhanced segmentation of peripheral airways and estimates of chronic perfusion deficits based on analysis of chest CT scans.

Facilitating timely detection and follow-up management of patients with aortic aneurysms, the PRAEVAorta2 software reportedly enables automated measurement of aortic diameters on computed tomography (CT) scans.

While a new meta-analysis of the PI-RADS v2.1 criteria showed 96 percent and 88 percent sensitivity rates for PI-RADS category > 3 and PI-RADS category > 4 assessments respectively, researchers noted a high risk of bias in 29 percent of the reviewed studies.

New enhancements for the Venue POCUS devices include automated labeling of anatomical landmarks with Nerveblox to facilitate 12 common peripheral nerve blocks and contrast-enhanced ultrasound geared to abdominal injury assessments.

In the second part of a recent interview, Emmanuel S. Antonarakis, M.D. discusses PSMA PET agents in current trials and cell surface proteins that may offer targeting utility in prostate cancer imaging beyond PSMA.

In the 160-patient study comparing 18F-PSMA 1007 PET/CT and 18F-NaF PET/CT, the use of 18F-PSMA PET/CT led to 38 patients being restaged as having more advanced prostate cancer.

Through enhanced data interoperability and access to patient histories, the cloud-based InteleHeart may facilitate better communication and workflow efficiencies for radiologists and cardiologists.

A deep learning AI platform, which incorporated radiomic features including CT attenuation metrics, demonstrated a 93.6 percent AUC for detecting invasive adenocarcinoma on chest CT.

The unforeseen impact of multiple variables has a way of wrecking any formal analysis of different compensation offers in radiology.

Catch up on the top radiology content of the past week.

Women who had an MRI prior to undergoing surgery for newly diagnosed breast cancer were 18 percent more likely to have a mastectomy, according to newly published research.

In a recent interview, Morris Panner offered his perspective on cultural hurdles to interoperability in health care, emerging trends with enterprise imaging and an answer first approach to integrating AI in radiology.

In a study involving over 500 patients, researchers noted that the CT-based AI software led to a 24 percent increase of evaluations for aortic abdominal aneurysms within six months of detection.

The AI-powered Bunkerhill MAC software reportedly facilitates chest CT detection and quantification of mitral annular calcification, which has been linked to higher cardiovascular risk and related mortality.

In a recent interview, Arthy Saravanan, M.D., discussed the recent launch of the Mammo Enhance Heart program from Radiology Partners and its potential impact in facilitating dual screening for breast cancer and cardiovascular risk.

The AI-powered Viz ACS platform may facilitate improved communication between clinicians and more rapid treatment for cases involving acute coronary syndrome.

Based on survey findings and subsequent voting from radiologists at nine facilities, the Society of Abdominal Radiology has issued new consensus recommendations on the use of adult abdominal photon-counting CT.

Researchers found comparable 10-year overall survival rates for people who had computed tomography (CT) surveillance (94.7 percent) and those who had surgery for ground-glass nodules (97.6 percent), according to a new prospective study involving over 680 participants.

In a recent interview, Emmanuel S. Antonarakis, M.D. discussed contributing factors to the recent American Cancer Society report about rising prostate cancer incidence and offered insights about the potential role of the radioligand agent 177Lu-PSMA-I&T for patients with mCRPC.

In a recent interview, Manisha Bahl, M.D., discussed new research showing significant associations between AI detection and the histologic grade and lymph node status of breast cancer.

Have you seen a fair share of laundry list R/Os from referring docs?

In a multicenter trial, researchers found 96.3 percent of women with low-risk, early-stage breast cancer had no local recurrence after being treated with a combination of ProSense cryoablation and hormone therapy.

Catch up on the top radiology content of the past week.

In comparison to false positives with unassisted radiologist interpretations of DBT exams, AI-only false positive assessments were associated with a significantly higher total of false-positive findings as well as a 33 percent lower frequency of dense breasts, according to a new study of nearly 3,000 women who had screening DBT exams.

New research shows that women, subspecialists and radiologists in non-academic settings had over a 25 percent higher attrition rate in radiology in comparison to men, general radiologists and academic radiologists.

For patients with relapsing multiple sclerosis, switching from oral therapies to subcutaneous monthly administration of the anti-CD20 monoclonal antibody ofatumumab led to over a 98 percent reduction of Gd+ T1 lesions on MRI at 96 weeks.